At its core, iFyber was founded on the principle of creatively solving problems at the interface between chemistry, biology, and materials science, and our team of scientists reflects this mission.
With varied models of engagement and a multidisciplinary team, including microbiologists, biomedical engineers, analytical chemists, and synthetic chemists, with commercial and regulatory team members, we can meet the diverse service needs of companies of all sizes across several industries.
Our team’s mission is to help our clients turn their technology into market-ready products. At all stages of product development, from exploratory research for conceptual evaluation to comparative marketing studies highlighting the benefits of your technology, we have the intended clinical use and potential regulatory pathway in mind.
- Our scientists are involved in every project step – from initial conversations and proposals to data analysis and reporting.
- We strive to build a culture of collaboration that fosters innovative and creative problem-solving through the open exchange of information and ideas.
- The strong relationships we build are paramount to our success in delivering high-quality service and fast, reliable results.
- Over 50% of our technical team holds advanced degrees (Ph.D., M.S.), demonstrating our commitment to hiring highly trained and skilled scientists.
Contact an iFyber scientist today to design the appropriate studies for your product or application.
Leadership
Greg joined iFyber as president in 2016 and is responsible for providing strategic leadership to the organization and creating and implementing processes supporting our core mission. He brings over 15 years of industry experience working with a range of companies, from medical device start-ups to mature established organizations. With a strong cross-functional background and understanding of the product development process, Greg has developed and executed the business and development plans of large multi-stakeholder projects for both medical device and applied market technologies. Over the last four years iFyber has increased in size by four-fold under Greg’s leadership, and he continues to successfully expand the business and our offerings through the development of successful corporate and government relationships and by building and maintaining a dynamic and innovative team.
Greg holds a B.S. and M.S. in mechanical engineering from Oregon State University.
Kelly joined iFyber in February of 2023 as a Vice President. Previously, she worked in the infectious disease medical device industry at ZeptoMetrix as Director of Virology for over 14 years. As Director, Kelly continually sourced viruses and developed novel product lines to expand the virology product portfolio and generate additional business. She worked closely with customers to provide viruses required for the analytical testing of diagnostic assays and designed custom studies to address various clients’ needs. As a VP at iFyber, Kelly continues to interface with customers, manage technical programs, and oversee the regulatory operations.If you’re interested in a position with iFyber, please visit our careers page for more information.